The long noncoding RNA Wisper controls cardiac fibrosis and remodeling-Reference-Cited by-同舟云学术

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

Published:2017-06-21 Issue:395 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Micheletti Rudi¹^ORCID,Plaisance Isabelle¹,Abraham Brian J.²^ORCID,Sarre Alexandre³,Ting Ching-Chia¹,Alexanian Michael¹,Maric Daniel¹,Maison Damien¹,Nemir Mohamed¹,Young Richard A.²⁴,Schroen Blanche⁵,González Arantxa⁶⁷^ORCID,Ounzain Samir¹,Pedrazzini Thierry¹^ORCID

Affiliation:

1. Experimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, Lausanne, Switzerland.

2. Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.

3. Cardiovascular Assessment Facility, University of Lausanne, Lausanne, Switzerland.

4. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

5. Center for Heart Failure Research, Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, Netherlands.

6. Centre for Applied Medical Research, University of Navarra, Pamplona, Spain.

7. National Institute of Health Carlos III, Madrid, Spain.

Abstract

A super-enhancer–associated long noncoding RNA, Wisper , controls cardiac fibrosis and pathological remodeling in the damaged heart.

Funder

Swiss National Science Foundation

Ministry of Economy and Competitiveness, Spain

Hope Funds for Cancer Research

The Netherlands Organization for Scientific Research

The Netherlands Heart Foundation

European Union

Publisher